SCHEMBL8064674

SCHEMBL8064674

COc1ccc(CC[C@@H](NC(=O)C(F)(F)F)C(=O)O)c(F)c1F

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
ATM Q13315 2/20 0.36
LMNA P02545 1/20 0.36
ALDH1A1 P00352 2/20 0.35
GAA P10253 1/20 0.35
KMT2A Q03164 3/20 0.35
MEN1 O00255 2/20 0.35
TAS1R3 Q7RTX0 1/20 0.34
TAS1R1 Q7RTX1 1/20 0.34
MRGPRX4 Q96LA9 1/20 0.34
FPR2 P25090 1/20 0.34
PPARD Q03181 1/20 0.33
PPARA Q07869 1/20 0.33
FOLH1 Q04609 1/20 0.33
ALOX15 P16050 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5889359 0.81 TAS1R3 (0.43) CYP1A2CYP2C9CYP2C19ATMLMNA
SCHEMBL5352189 0.81 TAS1R3 (0.43) CYP1A2CYP2C9CYP2C19ATMLMNA
SCHEMBL5889331 0.81 TAS1R3 (0.43) CYP1A2CYP2C9CYP2C19ATMLMNA
SCHEMBL7830420 0.81 LDHA (0.50) CYP1A2CYP2C9CYP2C19ATMALDH1A1
SCHEMBL7834588 0.81 LDHA (0.50) CYP1A2CYP2C9CYP2C19ATMALDH1A1
SCHEMBL6951996 0.76 ACE (0.41) FOLH1
SCHEMBL6951990 0.76 ACE (0.41) FOLH1
SCHEMBL5889370 0.74 HTT (0.50) CYP1A2CYP2C9CYP2C19LMNAALDH1A1
SCHEMBL5355623 0.74 HTT (0.50) CYP1A2CYP2C9CYP2C19LMNAALDH1A1
SCHEMBL5351455 0.74 HTT (0.50) CYP1A2CYP2C9CYP2C19LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1017667-A1 2-Amino-6-methyl-7-acetyl-tetraline and pharmaceutical compositions for the prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) 2000-07-12 EP disclosed
WO-1999015494-A1 2-AMINOTETRALINES, A PROCESS FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS, FOR THE PREVENTION AND THERAPEUTIC TREATMENT OF INFLAMMATORY AND/OR AUTOIMMUNE PATHOLOGIES SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 1999-04-01 WO disclosed